Repro Med Systems Inc (REPR) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Repro Med Systems Inc

CIK: 704440 Ticker: REPR

View differences made from one to another to evaluate Repro Med Systems Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Repro Med Systems Inc.


Assess how Repro Med Systems Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Repro Med Systems Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Repro Med Systems Inc provided additional information to their SEC Filing as exhibits

Ticker: REPR
CIK: 704440
Form Type: 8-K Corporate News
Accession Number: 0001161697-18-000509
Submitted to the SEC: Wed Oct 24 2018 5:27:41 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Wednesday, October 24, 2018
Industry: Surgical And Medical Instruments And Apparatus
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: